Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 12, 2008, Pages 1695-1700

  Gao, Ying ^a   Xue, Jing ^a   Li, Xiaoyu ^a   Jia, Yongqian ^b   Hu, Jing ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; FAT DROPLET; MESSENGER RNA; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRANSCRIPTION FACTOR RUNX2;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; RAT;

EID: 56849088732     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.12.0017     Document Type: Article

References (29)

1. Akune, T., Ohba, S., Kamekura, S., Yamaguchi, M., Chung, U., Kubota, N., Terauchi, Y., Harada, Y., Azuma, Y., Nakamura, K., Kadowaki, T., Kawaguchi, H. (2004) PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 113: 846-855
2. Backesjo, C. M., Li, Y., Lindgren, U., Haldosen, L. A. (2006) Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J. Bone Miner. Res. 21: 993-1002
3. Carnevale, V., Romagnoli, E., D'Erasmo, E. (2004) Skeletal involvement in patients with diabetes mellitus. Diabetes Metab. Res. Rev. 20: 196-204
4. Chau, D. L., Edelman, S. V., Chandran, M. (2003) Osteoporosis and diabetes. Curr. Diabetes Rep. 3: 37-42
5. Choi, Y. S., Park, S., Suh, H. (2005) Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres. Biomaterials 26: 5855-5863
6. Cortizo, A. M., Caporossi, M., Lettieri, G., Etcheverry, S. B. (2000) Vanadate-induced nitric oxide production: role in osteoblast growth and differentiation. Eur. J. Pharmacol. 400: 279-285
7. Cortizo, A. M., Sedlinsky, C., McCarthy, A. D., Blanco, A., Schurman, L. (2006) Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur. J. Pharmacol. 536: 38-46
8. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A., Karsenty, G. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754
9. 3 inhibit bone marrow adipogenesis in senescence acclerated mice(SAM-P/6) by decreasing the expression of peroxisome proliferatorsactivated receptor gamma2 (PPARγ2). Exp. Gerontol. 39: 333-338
10. Kajkenova, O., Lecka-Czernik, B., Gubrij, I., Hauser, S. P., Takahashi, K, Parfitt, A. M., Jilka, R. L., Manolagas, S. C., Lipschitz, D. A. (1997) Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J. Bone Miner. Res. 12: 1772-1779
11. Katayama, Y., Akatsu, T., Yamamoto, M., Kugai, N., Nagata, N. (1996) Role of non-enzymatic glycosylation of type I collagen in diabetic osteopenia. J. Bone Miner. Res. 11: 931-937
12. Kewalramani, D. A. G., Chan, J. K. Y., Qi, D., Ghosh, S., Pulinilkunnil, T., Abraham, A., Innis, S. M., Rodrigues, B. (2006) Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3. Diabetes 49: 2174-2184
13. KraKauer, J. C., McKenna, M. J., Buderer, N. F., Rao, D. S., Whitehouse, F. W., Parfitt, A. M. (1995) Bone loss and bone turnover in diabetes. Diabetes 44: 775-782
14. Lecka-Czernik, B., Gubrij, I., Moerman, E. J., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C., Jilka, R. J. (1999) Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J. Cell Biochem. 74: 357-371
15. Lecka-Czernik, B., Moerman, E. J., Grant, D. F., Lehmann, J. M., Manolagas, S. C., Jilka, R. L. (2002) Divergent effects of selective peroxisome proliferators-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143: 2367-2384
16. Lehmann, J. M., Morre, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., Kliewer, S. A. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferators-activated receptor γ (PPARγ). J. Biol. Chem. 70: 12953-12956
17. Leskela, H. V., Olkku, A., Lehtonen, S., Mahonen, A., Koivunen, J., Turpeinen, M., Uusitalo, J., Pelkonen, O., Kangas, L., Selander, K., Lehenkari, P. (2006) Estrogen receptor alpha genotype confers interindividual variability of response to estrogen and testosterone in mesenchymal-stem-cell-derived osteoblasts. Bone 39: 1026-1034
18. McCarthy, A. D., Etcheverry, S. B., Bruzzone, L., Cortizo, A. M. (1997) Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells. Mol. Cell Biochem. 170: 43-51
19. Nuttall, M. E., Gimble, J. M. (2004) Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr. Opin. Pharmacol. 4: 290-294
20. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Dougglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147
21. Rouru, J., Isaksson, K., Santti, E., Huupponen, R., Koulu, M. (1993) Metformin and brown adipose tissue thermogenetic activity in genetically obese Zucker rats. Eur. J. Pharmacol. 246: 67-71
22. Schwartz, A. V., Sellmeyer, D. E. (2008) Effect of thiazolidine-diones on skeletal health in women with type 2 diabetes. Expert Opin. Drug Safety 7: 69-78
23. Sugiura, F., Kitoh, H., Ishiguro, N. (2004) Osteogenic potential of rat mesenchymal stem cells after several passages. Biochem. Biophy. Res. Commun. 316: 233-239
24. Tang, Z. H., Sahu, S. N., Khadeer, M. A., Bai, G., Franklin, R. B., Gupta, A. (2006) Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells. Bone 38: 181-198
25. Vestergaard, P., Rejnmark, L., Mosekilde, L. (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48: 1292-1299
26. Wilcock, C., Bailey, C. J. (1991) Reconsideration of inhibitory effect of metformin on intestinal glucose absorption. J. Pharm. Pharmacol. 43: 120-121
27. Yamagishi, S., Nakamura, K., Inoue, H. (2005) Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Med. Hypotheses 65: 1013-1015
28. Zhang, S. Q., Zhong, X. Y., Chen, G. H., Lu, W. L., Zhang, Q. (2008) The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats. J. Pharm. Pharmacol. 60: 99-105
29. Zheng, H., Guo, Z., Ma, Q., Jia, H., Dang, G. (2004) Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in-vitro and in vivo. Calcif. Tissue Int. 74: 194-203